Intervention Review

Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome

  1. Michael F Costello1,*,
  2. Bhushan Shrestha2,
  3. John Eden3,
  4. Neil Johnson4,
  5. Lisa J Moran5

Editorial Group: Cochrane Gynaecology and Fertility Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 14 NOV 2006

DOI: 10.1002/14651858.CD005552.pub2


How to Cite

Costello MF, Shrestha B, Eden J, Johnson N, Moran LJ. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005552. DOI: 10.1002/14651858.CD005552.pub2.

Author Information

  1. 1

    School of Women's & Children's Health, Royal Hospital for Women and IVF Australia, Division of Obstetrics & Gynaecology, Sydney, Australia

  2. 2

    University of New South Wales, School of public health and community medicine, Concord, NSW, Australia

  3. 3

    Royal Hospital for Women, Sydney Menopause Centre & Natural Therapies Unit, Randwick, NSW, Australia

  4. 4

    University of Auckland, Department of Obstetrics & Gynaecology, Auckland, New Zealand

  5. 5

    Monash University, The Jean Hailes Clinical Research Unit, School of Public Health and Preventive Medicine, Clayton, Victoria, Australia

*Michael F Costello, Division of Obstetrics & Gynaecology, School of Women's & Children's Health, Royal Hospital for Women and IVF Australia, Barker Street, Randwick, Sydney, NSW 2031, Australia. mfcostello@unsw.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007

SEARCH